China CAS:57-83-0 Manufacturer

We are commitment to offer the competitive price ,outstanding products quality, as well as fast delivery for CAS:57-83-0, With our rules of " small business track record, partner trust and mutual benefit", welcome all of you to definitely work together , expand with each other.
CAS:57-83-0, Our aim is to help customers realize their goals. We have been making great efforts to achieve this win-win situation and sincerely welcome you to join us. In a word, when you choose us, you choose a perfect life. Welcome to visit our factory and welcome your order! For further inquiries, remember to do not hesitate to contact us.

Hot Products

  • Cyproterone Acetate

    Cyproterone Acetate

    For Cyproterone Acetate (CPA), we have CP and EP specifications, CEP/TGA/EU-GMP available.

    CAS:427-51-0

  • Medroxyprogesterone Acetate

    Medroxyprogesterone Acetate

    Medroxyprogesterone Acetate has USP、EP、 IP、JP and KP. DMF, GMP is available.

    CAS:71-58-9

  • 16-Dehydropregnenolone Acetate (16-DPA)

    16-Dehydropregnenolone Acetate (16-DPA)

    16-Dehydropregnenolone Acetate (16-DPA) is the dehydration product of Pregnenolone Acetate..

    CAS:979-02-2

  • Triacetyl-ganciclovir

    Triacetyl-ganciclovir

    Triacetyl-ganciclovir is a Ganciclovir derivative.

    CAS:86357-14-4

  • Cbz-Valganciclovir

    Cbz-Valganciclovir

    Cbz-Valganciclovir,N-Carbobenzyloxy-L-valinyl-ganciclovir (cas# 194154-40-0) is a compound useful in organic synthesis.

    CAS:194154-40-0

  • 16alpha-Hydroxyprednisolone Acetate

    16alpha-Hydroxyprednisolone Acetate

    16alpha-Hydroxyprednisolone Acetate is used to observe interaction of some steroid drugs with β-cyclodextrin polymer to calculate the relative strengh of interaction between the hydrophobicity parameters of the drugs and the strenght of the drug-β-​cyclodextrin polymer.

    CAS:86401-80-1

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept